175 related articles for article (PubMed ID: 25038987)
1. Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4).
Woodard LE; De Silva RA; Behnam Azad B; Lisok A; Pullambhatla M; G Lesniak W; Mease RC; Pomper MG; Nimmagadda S
Nucl Med Biol; 2014 Aug; 41(7):552-61. PubMed ID: 25038987
[TBL] [Abstract][Full Text] [Related]
2.
Burke BP; Miranda CS; Lee RE; Renard I; Nigam S; Clemente GS; D'Huys T; Ruest T; Domarkas J; Thompson JA; Hubin TJ; Schols D; Cawthorne CJ; Archibald SJ
J Nucl Med; 2020 Jan; 61(1):123-128. PubMed ID: 31201250
[TBL] [Abstract][Full Text] [Related]
3. Imaging CXCR4 expression in human cancer xenografts: evaluation of monocyclam 64Cu-AMD3465.
De Silva RA; Peyre K; Pullambhatla M; Fox JJ; Pomper MG; Nimmagadda S
J Nucl Med; 2011 Jun; 52(6):986-93. PubMed ID: 21622896
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of N-[(11)C]methyl-AMD3465 as a PET tracer for imaging of CXCR4 receptor expression in a C6 glioma tumor model.
Hartimath SV; van Waarde A; Dierckx RA; de Vries EF
Mol Pharm; 2014 Nov; 11(11):3810-7. PubMed ID: 25094028
[TBL] [Abstract][Full Text] [Related]
5. Development and Evaluation of an
Brickute D; Braga M; Kaliszczak MA; Barnes C; Lau D; Carroll L; Stevens E; Trousil S; Alam IS; Nguyen QD; Aboagye EO
Mol Pharm; 2019 May; 16(5):2106-2117. PubMed ID: 30883140
[TBL] [Abstract][Full Text] [Related]
6. In vivo validation of
Renard I; Domarkas J; Poty S; Burke BP; Roberts DP; Goze C; Denat F; Cawthorne CJ; Archibald SJ
Nucl Med Biol; 2023; 120-121():108335. PubMed ID: 37068392
[TBL] [Abstract][Full Text] [Related]
7. Imaging CXCR4 Expression with Iodinated and Brominated Cyclam Derivatives.
Zhang H; Maeda M; Shindo M; Ko M; Mane M; Grommes C; Weber W; Blasberg R
Mol Imaging Biol; 2020 Oct; 22(5):1184-1196. PubMed ID: 32239371
[TBL] [Abstract][Full Text] [Related]
8. In vivo Evaluation of an Engineered Cyclotide as Specific CXCR4 Imaging Reagent.
Lesniak WG; Aboye T; Chatterjee S; Camarero JA; Nimmagadda S
Chemistry; 2017 Oct; 23(58):14469-14475. PubMed ID: 28771849
[TBL] [Abstract][Full Text] [Related]
9. [
Amor-Coarasa A; Kelly J; Ponnala S; Vedvyas Y; Nikolopoulou A; Williams C; Jin MM; David Warren J; Babich JW
Nucl Med Biol; 2018 May; 60():37-44. PubMed ID: 29544122
[TBL] [Abstract][Full Text] [Related]
10. Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT.
Nimmagadda S; Pullambhatla M; Pomper MG
J Nucl Med; 2009 Jul; 50(7):1124-30. PubMed ID: 19525448
[TBL] [Abstract][Full Text] [Related]
11. CXCR4-targeted PET imaging using
Muz B; Bandara N; Mpoy C; Sun J; Alhallak K; Azab F; Rogers BE; Azab AK
Cancer Biol Ther; 2020; 21(1):52-60. PubMed ID: 31571524
[No Abstract] [Full Text] [Related]
12. High-Contrast CXCR4-Targeted
Kwon D; Lozada J; Zhang Z; Zeisler J; Poon R; Zhang C; Roxin Á; Lin KS; Perrin D; Benard F
Mol Pharm; 2021 Jan; 18(1):187-197. PubMed ID: 33253591
[TBL] [Abstract][Full Text] [Related]
13. N-[
Hartimath SV; Khayum MA; van Waarde A; Dierckx RAJO; de Vries EFJ
Mol Imaging Biol; 2017 Aug; 19(4):570-577. PubMed ID: 27896627
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization and in vivo evaluation of β-Hairpin peptidomimetics as specific CXCR4 imaging agents.
Lesniak WG; Sikorska E; Shallal H; Behnam Azad B; Lisok A; Pullambhatla M; Pomper MG; Nimmagadda S
Mol Pharm; 2015 Mar; 12(3):941-53. PubMed ID: 25590535
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100.
Weiss ID; Jacobson O; Kiesewetter DO; Jacobus JP; Szajek LP; Chen X; Farber JM
Mol Imaging Biol; 2012 Feb; 14(1):106-14. PubMed ID: 21347799
[TBL] [Abstract][Full Text] [Related]
16. PET of tumor CXCR4 expression with 4-18F-T140.
Jacobson O; Weiss ID; Kiesewetter DO; Farber JM; Chen X
J Nucl Med; 2010 Nov; 51(11):1796-804. PubMed ID: 20956475
[TBL] [Abstract][Full Text] [Related]
17. Comparison of (18)F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression.
Zhang XX; Sun Z; Guo J; Wang Z; Wu C; Niu G; Ma Y; Kiesewetter DO; Chen X
Mol Imaging Biol; 2013 Dec; 15(6):758-67. PubMed ID: 23636490
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of an (18)F-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in gliomas.
Demoin DW; Shindo M; Zhang H; Edwards KJ; Serganova I; Pillarsetty NV; Lewis JS; Blasberg RG
Nucl Med Biol; 2016 Oct; 43(10):606-11. PubMed ID: 27485481
[TBL] [Abstract][Full Text] [Related]
19. Therapy-Induced Changes in CXCR4 Expression in Tumor Xenografts Can Be Monitored Noninvasively with N-[
Hartimath SV; Draghiciu O; Daemen T; Nijman HW; van Waarde A; Dierckx RAJO; de Vries EFJ
Mol Imaging Biol; 2020 Aug; 22(4):883-890. PubMed ID: 31802362
[TBL] [Abstract][Full Text] [Related]
20. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.
Gourni E; Demmer O; Schottelius M; D'Alessandria C; Schulz S; Dijkgraaf I; Schumacher U; Schwaiger M; Kessler H; Wester HJ
J Nucl Med; 2011 Nov; 52(11):1803-10. PubMed ID: 22045709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
